Read the
May 22, 2017 – Where To Invest Now Newsletter in .pdf format – HERE
Where To Invest Now Newsletter
May 22, 2017
Market Strategies Sample Issue
Balanced Investing Strategies To Make Money In Up Or Down Markets
A Publication of Princeton Research, Inc. (www.PrincetonResearch.com)
Contributing Staff: Michael King, Charles Moskowitz
Proven Trading Success
Results From Our Recent Trade Alerts:
163% Profits on SPY Calls in 2 Days
20% Profits on AGQ Calls in 15 Days
100% Profits on SPY Calls in 2 Days
8% Loss on SPY Puts in 1 Day
100% Loss On VRX Calls in 30 Days
89% Profits on SPY Calls in 1 Day
15% Loss on SPY Calls in 2 Days
66% Loss on SCO Calls in 7 Days
41% Profits on SPY Puts in 6 Days
125% Profits on OIH Calls in 6 Days
130% Profits on GS Calls in 9 Days
217% Profits on XOM Calls in 9 Days
205% Profits on XOM Calls in 3 Days
105% Profits on XOM Calls in 3 Days
50% Loss on NUGT Calls in 10 Days
50% Loss on SJM Calls in 7 Days
117% Profits on GLD Calls in 3 days
50% Loss on GLD Calls in 20 days
62% Profits on XOM Calls in 20 days
50% Loss on HL Calls in 2 Days
50% Profits on PFE Calls in 2 Days
50% Loss on SPY Puts in 2 Days
50% Loss on TWTR Calls in 8 Days
31% Profits TWTR Calls in 2 Days
316% Profits on MOS Calls in 13 Days
154% Profits on MOS Calls in 11 Days
100% Profits on MOS Calls in 8 Days
See all trades in past newsletter issues.
Remember, these trades are based on your participation in the
Subscriber Members Only
TEXTING SERVICE TO RECEIVE ALL UPDATES.
New Trades Will Be TEXTED To MEMBERS
For Free Where To Invest Your Money Now
High Return Investments Trade Alerts
Go To: PrincetonResearch.com/alerts.htm
SPECIAL RATES Available for VIP MEMBERSHIP
Get the lowest full membership rates available.
NOTE: This is a Sample Issue Only!
TO GET OUR TRADE ALERTS BY TEXT MESSAGE AND
THE COMPLETE VIP MEMBERS ONLY MARKET STRATEGIES NEWSLETTER ISSUES
Visit: PrincetonResearch.com/join.htm
Follow Our Marketed Weathered,
Time Tested Trading Rules That
PROTECT YOUR CAPITAL And SECURE PROFITS
Now you can profit from investing trade alerts from our traders with over 75 combined years of successful investing experience.
- Make Money In Up Or Down Markets — Our trading alerts balanced investing strategies are designed and proven to make money in up or down markets.
- Done For You – All the stock options picking, research and trading analysis is done for subscribers. This is not a ‘class’ or a ‘training course’… this is us doing ALL the work… from research to sending you a text on what to trade, along with recommended amounts…
- SAFETY – We strictly follow our Tested, Market Weathered Trading Rules that are proven time and time again to protect our (and now your) investment capital from losses while effectively allowing us to Keep The Profits We Make.
So even though we trade options to get the profits you see above — We can do it with minimal risk and Maximum Profit Potential.
You Don’t Need To Learn Any Trading Skills Or
Do Any Time Consuming Analysis and Tracking
+++ We DO IT ALL FOR YOU! +++
We tell you where, when and how much to trade and you get to sit back and enjoy the rewards!
The specific buy and sell trading alerts are sent directly to you by e-mail and text message. So you can get in on and cash out on our winning trades fast and at the right time.
Get Started with Any Amount – Follow our recommended trading guidelines for a $10,000 portfolio or invest more or invest less — Whatever you are comfortable with. Your investment is protected because Time Tested Trading Rules PROTECT YOUR CAPITAL And KEEP YOUR PROFITS.
Join Us Today.
Lock in the Lowest Membership Rates Available HERE
2 FOR 1 BONUS:
Your Membership includes access to both:
Trade Alerts by Text Message and e-mail
AND
The Market Investing Strategies Newsletter
Full Members Only Edition
Our Where To Invest Now For Profits In Up or Down Markets Newsletter is more compact, informative, effective and quicker to read then the major, big name publications. AND there are NO ADS to wade through.
The Members Edition Newsletter is sent to you by e-mail Monday Mornings and available in the Members Area along with our archive of past issues.
A Sample of the Where To Invest Now Newsletter
Information Our Members Get Follows
Investing Trade Alerts
Charles Moskowitz Discussion
Clearly, as shown by the massive selloff on Wednesday, we are not immune to meaningful setbacks in this market, although clearly there is plenty of “buy the dips” cash sitting on the sidelines. The most important feature of this sell-off (to my way of thinking) was the closure of the back to back gaps that occurred on April 24th and 25th that covered a move of almost 500 Dow points. While not all gaps get closed, when you move 2.5% in 2 days the healthy move is to at least test if not close that gap, and now we have that closure.
Some of the talking heads have blamed the sell-off on the political issues and comparisons to Nixon which I find absurd since Nixon was the consummate crooked and entrenched politician, whereas Trump has no clue. I have always said that political and geopolitical issues can turn market sentiment on a dime and this was the best example come home to roost…CAM
Where To Invest Now
Investing Trade Alerts Summary
$10,000 Trading Account Trade Table
DATE |
TRADES |
PRICE |
COST |
PROCEEDS |
RESULTS |
05/19 |
Sold 10 SPY May 19th 238 Puts |
0.15 |
150 |
10 Loss |
|
05/19 |
Bought 10 SPY May 19th 238 Puts |
0.16 |
160 |
||
05/18 |
Sold 10 SPY May 19th 236 Puts |
0.30 |
300 |
80 Loss |
|
05/18 |
Bought 10 SPY May 19th 236 Puts |
0.38 |
380 |
||
05/18 |
Sold 10 SPY May 19th 236.50 Calls |
0.69 |
690 |
110 Gain |
|
05/18 |
Bought 10 SPY May 19th 236.50 Calls |
0.58 |
580 |
||
05/18 |
Bought to cover 10 SPY May 19th 238.50 Calls |
0.06 |
60 |
650 Gain |
|
05/17 |
Sold Short 10 SPY May 19th 238.50 Calls |
0.71 |
710 |
||
05/17 |
Sold 10 SPY May 19th 239 Calls( 50% Loss Rule ) |
0.22 |
220 |
220 Loss |
|
05/17 |
Bought 10 SPY May 19th 239 Calls |
0.44 |
440 |
||
05/16 |
Sold 7 SPY May 17th 240 Calls |
0.59 |
413 |
161 Gain |
|
05/15 |
Bought 10 JBLU June 28th Calls |
0.40 |
400 |
||
05/15 |
Sold 8 SPY May 17th 240 Calls |
0.72 |
576 |
288 Gain |
|
05/15 |
Bought 15 SPY May 17th 240 Calls |
0.36 |
540 |
||
05/01 |
Bought 2 SJM June $ 170 Calls |
1.70 |
340 |
||
05/01 |
Bought 2 SJM June $ 130 Calls |
1.60 |
320 |
||
04/21 |
Bought 10 HL June 6th $ 6 Calls |
0.24 |
240 |
3rd Week expiration when the month is listed without a date
Previous closed out trades not listed here may be seen in previous market letters in the
VIP Subscribers Members Area.
Remember, these trades are based on your participation in the
Subscriber Members Only
TEXTING SERVICE TO RECEIVE ALL UPDATES.
Where To Invest Now
MARKET Laboratory – Market Indicators Weekly Changes
Prices are copied from Barron’s Weekly and Yahoo Finance and may be incorrect.
| Dow
20,804.84 -91.77 -0.44% |
Nasdaq
6083.70 -37.53 -0.61% |
S&P 500
2381.73 -9.17 -0.38% |
Transportation
8879.19 -121.95 -1.35% |
Russell 2000
1367.33 -15.44 -1.12% |
Nasdaq100
5651.56 -35.25 -0.62% |
| Gold (spot)
1252.70 +26.50 +2.2% |
Silver July
16.796 +0.394 +2.4% |
Crude June
50.33 +2.49 +5.2% |
Heating Oil
158.27 +8.94 +6.0% |
Unleaded Gas
1.6523 +7.62 +4.8% |
Natural Gas
3.256 -0.168 -4.9% |
| VIX
12.04 +1.64 +15.8% |
Put/Call Ratios
S&P 100 136/100’s +27/100’s |
Put/Call Ratios
CBOE Equity 63/100’s +2/100’s
|
Bonds
153-27 +2-13 2.95% -0-04% |
10 Yr. Note
126-06 +31 2.26%-0-06%
|
Copper
258.15 +5.75 +2.3% |
| CRB Inflation
Index 185.08. +3.39 +1.9% |
Barron’s* Confidence
75.3 -1.7 |
S&P100
1050.79 -6.02 -0.57% |
5 Yr. Note
118-207+ 0-18 1.79% -0.06%
|
Dollar
97.12 -2.07 -2.1% |
DJ Utilities
703.27 +2.98 +0.43% |
| AAII
Confidence Index
Average |
Bullish
23.9% -8.8%
38.4% |
Bearish
34.3% +4.1%
30.30% |
Neutral
41.8% +4.7%
30.96%
|
M1 Money
Supply +6.85%
May 8th |
M2 Money
Supply +5.93%
May 8th
|
* Component Change in the Confidence Index
M1…all money in hands of the public, Time Deposits Traveler’s Checks, Demand Deposits
M2.. adds Savings and Money Market Accounts both compared with the previous year.
Where To Invest Now
Market Strategies Technical Information
SUPPORT RESISTANCE
S&P 500 2350 2410
NASDAQ (QQQ) 135.20 140.50
Trans 8750 9320
DOW 20,500 21,080
TLT 120.70 125.00
Where To Invest Now
Market Strategies $100,000 Trading Account
There were seven closed out options positions last week, all S&P trades gaining $ 1,785.
They are all listed in the next section table.
The best trade was the short sale of 20 May 19th 238.50 Calls at $ 0.71, covered the next day at just $ 0.06 for a profit of $ 1,300.
The worst loss was the purchase of 20 SPY Calls at $ 0.44 on May 17th; sold at $ 0.22 for a deficit of $ 440.
The options expire on the third Friday of each Month unless otherwise posted.
The Stock table has the following 18 positions:
AGQ, AMBA, EYES ( 2 ), GSAT, HL, MOS ( 2 ), NUGT, REPR, RWM,
SAN, SLV, SPXU, TEXQY, TWTR, VRX (2)
:
The options call for a $ 2,500 investment unless otherwise stated; each stock position requires $5,000 unless otherwise mentioned specifically.
Money management is based on a hypothetical $ 100,000.
The 18 stock positions would cost $ 73,994.
The long options positions, the 10 HL June 6 Calls, the JBLU June $ 28 Calls and the 8 SJM June 130 Calls would require $ 2,600
when combined with the stock requirement of $ 73,994
equals $76,594
which leaves excess cash of $ 23,406.
These figures are approximate and there might be errors.
The trading is hypothetical and we do not count commission costs.
Executions that have occurred at or near the open or close of trading sometimes vary from our actual numbers. For example, when something opens down and it is through our price, we take the next trade whether it is an uptick or continues lower. This sometimes results in a 50% trade that is slightly above or below the exact number.
Where To Invest Now
Market Strategies Cycles
Alibaba Group Holding Limited (NYSE:BABA: $ 123.22 ) + $ 1.95 or + 1.6% held its ground even with lackluster earnings. It has technology that enables merchants, brands and other businesses to transform the way they market, sell and operate in China and internationally. Retail commerce in China operated by the Company includes the China online commerce destination (Taobao Marketplace); the China third-party platform for brands and retailers (Tmall), and the sales and marketing platform for flash sales (Juhuasuan). Wholesale commerce in China operated by the Company includes the China domestic wholesale marketplace (1688.com) and the wholesale marketplace for global trade (Alibaba.com). BABA is one of the world’s largest retailers.
Amazon ( AMZN: $ 959.84 )- $ 1.51 or – 0.15%: is a buy on a sell-off in the general market.: It celebrated its 20th anniversary as a public company. Amazon’s stock has risen 49,000%. A $5,000 investment in the online retailer in 1997 would be worth $2.4 million today. The meteoric rise of Amazon’s stock price gives us an excellent opportunity to examine the tenets of value investing. Today, Amazon’s market cap is about $465 billion, which ranks it 4th largest. Apple is number 1 at $ 757.51 Bln; GOOGL number 2 at $ 660Bln; GOOG number 3 at $646Bln Microsoft number 3 at $522.6 Bil.
Largest U.S. Companies by Market Capitalization
Large Cap Company Ticker Market Cap
($in billions)
Apple Inc AAPL 797.51
Alphabet Inc GOOGL 660.38
Microsoft Corporation MSFT 522.60
Amazon.com Inc. AMZN 458.78
Facebook Inc FB 429.10
Berkshire Hathaway Inc. BRK.A 402.63
Exxon Mobil Corp XOM 347.16
Johnson & Johnson JNJ 342.12
JPMorgan Chase & Co JPM 301.21
Wells Fargo & Co. WFC 265.16
General Electric Co GE 243.59
Bank of America Corp. BAC 242.40
Wal-Mart Stores, Inc. WMT 238.80
AT&T Inc T 235.10
Procter & Gamble Co. PG 220.57
Berkshire Hathaway Inc BRK.B 214.42
Visa Inc V 213.30
Chevron Corporation CVX 201.81
Pfizer Inc PFE 193.72
Where To Invest Now
Market Strategies Economic Data
Industrial Production increased 1.0% in April well above the Briefing.com consensus of +0.3% on the heels of a downwardly revised 0.4% increase from 0.5% in March. Total industrial production is up 2.2% year-over-year while total industry capacity growth has risen 0.7%
The Capacity Utilization rate jumped to 76.7% (Briefing.com consensus 76.2%) from 76.1% in March and is 3.2 percentage points below its long-run average.
The uptick in manufacturing output followed an unrevised 0.4% decline in March and it featured a 1.0% increase in the indexes for both durables and nondurables.
Motor vehicle assemblies jumped to a seasonally adjusted annual rate of 11.93 million units in April from 11.20 million units in March
Housing Starts ran at a seasonally adjusted annual rate of 1.172 million in April (Briefing.com consensus 1.255 mln), down 2.6% from a downwardly revised rate of 1.203 million (from 1.215 mln) for March. The downturn in starts was driven by a 9.2% decline in multi-unit dwellings, while single-family starts were up just 0.4%.
Building Permits declined 2.5% to a seasonally adjusted annual rate of 1.229 million (Briefing.com consensus 1.270 mln), which featured a disappointing 4.5% drop in permits for single-family units
Single-family starts declined 29.2% in the Northeast, increased 19.4% in the Midwest, declined 3.4% in the South, and increased 9.1% in the West
Single-family building permits declined 1.9% in the Northeast, declined 3.1% in the Midwest, declined 7.9% in the South, and increased 2.1% in the West.
Where To Invest Now
Undervalued Small Cap Stocks
Lower Priced stocks that look to be a buy are featured here.
Lower Capitalized Companies with Great Potential:
Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR)
(“RMS” or the “Company”) is pleased to announce that the umbrella organization of the public health insurance in Germany approved the FREEDOM60® Infusion System for reimbursement. The FREEDOM60® System was registered January, 31st 2017 and listed in the Medical Device Registry in the category mechanical infusion pumps. It is the ONLY device of its kind registered within Germany.
In partnership with ContraCare GmbH, a leader in Germany for Contract Management (reimbursement services) and managed Care, the RMS FREEDOM60®, FreedomEdge®, RMS Precision Flow Rate Tubing™ and RMS HIgH-Flo Subcutaneous Safety Needle Sets™ are now poised to dominate this growing market in Europe.
The United States Food and Drug Administration (“FDA”) renewed the Company’s Certificate to Foreign Government (“CFG”). A CFG is issued for legally marketed devices in the U.S. that are in compliance with the requirements of the Federal Food, Drug, and Cosmetic Act (“FFDCA”). A CFG is required by many market regulators in Asia, Europe, the Middle East and Latin America in order to legally sell medical devices in their territories. The renewal of this CFG confirms RMS devices have been cleared for sale in the U.S. and are in compliance with the requirements of the FFDCA. The CFG can be presented to regulators in foreign markets as part of the medical device registration process. Foreign governments often seek official assurance that products exported to their countries can be marketed in the U.S. and meet specific U.S. regulations, for example, current Good Manufacturing Practice (“cGMP”) regulations and Quality System Regulations (“QSR”).
Torsten Kühn, Chief Executive Officer of ContraCare, commented “as a premium service provider in Germany’s health care system, we aim to partner with leading suppliers to provide the best drugs, medical devices and services to our patients while keeping an eye on the cost efficiency of the treatments we provide. The RMS FREEDOM60® system with its durable and reliable syringe driver and high-quality HIgH-Flo™ subcutaneous safety needle sets are exactly the products we needed for immunoglobulin, antibiotic and many other therapies we are providing today. We are glad that the umbrella organization of Germany’s public health insurance confirms the unmet need by approving the RMS FREEDOM60® System for reimbursement.”
Eric Bauer, Chief Operating Officer of RMS commented, “It can take 12 to 14 months to obtain country registration; by partnering with a leading health care provider, that time was cut significantly. Contra Care is an exceptional partner and we could not be more pleased with our relationship. Germany is going to be a great market for our high quality products and our ever expanding product line. RMS continues to be the Global industry leader and create exceptional partnerships around the world to improve patient quality of life.”
RMS Medical Products is the leading manufacturer of medical products used for home infusions and suctioning. The Infusion product portfolio currently includes the FREEDOM60® and our latest Freedom Edge® Syringe Infusion Drivers, RMS Precision Flow Rate Tubing™ and RMS HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in professional healthcare settings as well as at home. The Company’s RES-Q-VAC® line of medical suctioning products is used by emergency medical service providers in addition to a variety of other healthcare providers. The Company’s website may be visited at www.rmsmedicalproducts.com.
Contra Care GmbH, based in Nuremberg, Germany, is specialized in providing Contract Management (reimbursement) Services and managed Care (homecare) solutions for patients with chronic diseases. The company is certificated in accordance with ISO 9001, ISO 27001, ISO 13485 and licensed as a homecare provider of medical devices and treatment services according to German Social Law (SGB).
Enzo Biochem ( ENZ: $ 9.02 )
Enzo Biochem closed the calendar year 2016 at $6.94 a share. For the year it was up 54.22% versus the Dow Jones +13%. The relative strength index was 53.41 which is neutral and short interest declined to 827,800 shares. However the RSI has climbed to over 80 and is now 69.08 on April 1st, 2017. Enzo’s balance sheet closed their first quarter October 31 with $67 million in cash and current equivalents and complete elimination of debt. Both the Clinical Lab and Life Science divisions ended the year profitably. New products were added to their catalog and litigations have moved ahead leaving them as a plaintiff with 6 lawsuits in the Delaware Court and one in the Manhattan Court.
What do I look for in 2017? The market will be interesting in the first half with the Government transition to a new administration. Abbots Summary Judgement request was denied by the Court but the trial date has yet to be set. At some point the 2nd Court of Appeals will rule on Enzo’s appeal on the CT. Courts reversal of the Jury’s decision in the Enzo vs. Apalera Case. The market is giving no value, win or lose, to this decision. The stake is $65 million with no adverse effect if ruled against Enzo. Enzo should again outperform the Dow and S&P in 2017.
Updates on Delaware Litigation
The last earnings report showed a cash position in excess of $65 million with no debt to speak of and a positive cash flow from their operating divisions. The only cash burn is coming from Litigation expenses and a bit from Research and Development. Litigation in Delaware is on a contingency basis as such Enzo is not on the hook for billable hours. To my knowledge there are 6 suits left after 6 have settled.
When the company gets a 500 million dollar market cap ($10.63) they will qualify for those Institutions that can’t buy microcap stocks. A significant number of Institutions will look to be buyers and with only 47 million shares issued and Institutions already owning 50% and insiders owning 15% that leaves less than 17 million shares in the float.
Pressure Bio Sciences OTCQB: PBIO ( 0.22 )*
Recently announced the signing of a new CFO Mr. Joseph L. Damasio Jr. Mr. Damasio has over 20 years of finance and accounting experience most recently as Finance Director at Nelipak Packaging, a private equity backed medical packaging manufacturer with over $ 100 million in global annual sales. Before joining Nelipak, Mr. Damasio held financial positions at CP Bourg, IQEKC, and Kopin Corporation. Mr Damasio was employed by Pressure BioSciences as both accounting manager (2007) and controller (2008) and finally as Vice President of Finance and Administration (2011).
The hiring of Mr Damasio will allow the Company’s CEO Mr Richard T Schumacher, who has been the company’s interim CFO for the past two years, and who has been a successful serial life sciences entrepreneur with three successful publicly traded companies to his credit, time to focus on critical operational issues in 2017. Some issues to be attended to include a pending up-list to NASADAQ and their stated goal to build a field sales team this year.
PBIO Develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. To date, they have installed over 250 PCT systems in approximately 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders.
NEEDS IN MEDICINE: In the world of medicine our dramatically improved ability for early detection or to confirm and refine diagnosis ranging from over a hundred types of cancer to tuberculosis and a hundred other maladies and conditions is “bottlenecked” by 30 year old methods of preparing test samples. Collectively such diagnostic samples exceed a hundred million annually.
NEEDS IN RESEARCH: Globally there are over a half a million medical and pharmaceutical research scientists working in over eighty thousand laboratories who are hampered by the time consuming and outdated methods of preparing test samples.
NEEDS IN FORENSICS: Globally, in millions of cases, swift and sure exoneration of the innocent and / or justice for the guilty is often delayed or even denied because of the ponderous means of preparing and conducting DNA and other forensic testing.
PBIO is focused on solving the challenges of biological sample preparation, a crucial laboratory step performed globally by the biological life sciences research scientists. Sample preparation refers to a wide range of activities that precede most forms of scientific analysis. It is often complex, time-consuming and, in our opinion, one of the most error-prone steps of scientific research. Sample preparation is a ubiquitous laboratory undertaking – the requirements of which drive a large and growing worldwide market. PBIO has developed and patented a novel, enabling technology platform that can control the sample preparation process while improving both efficacy and quality. It is based on harnessing the unique properties of high hydrostatic pressure. This process, called pressure cycling technology, or PCT, uses alternating cycles of hydrostatic pressure between ambient (normal atmosphere) and ultra-high levels i.e., 35,000 pounds per square inch (“psi”) or greater to safely, conveniently and reproducibly control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant and microbial sources.
The PBIO pressure cycling technology uses proprietary and internally developed instrumentation that is capable of cycling pressure between ambient and ultra-high levels at controlled temperatures and specific time intervals, to rapidly and repeatedly control the interactions of bio-molecules, such as deoxyribonucleic acid (“DNA”), ribonucleic acid (“RNA”), proteins, lipids and small molecules. Their laboratory instrument, the Barocycler®, and their internally developed consumables product line, which include Pressure Used to Lyse Samples for Extraction (“PULSE”) tubes, and other processing tubes, and application specific kits such as consumable products and reagents, together make up their PCT Sample Preparation System (“PCT SPS”).
The PBIO pressure cycling technology takes a unique approach that has the potential for broad use in a number of established and emerging life sciences areas, which include:
- Biological sample preparation in potentially thousands of research laboratories worldwide working in human, animal, plant, and microbial diseases and disorders – including but not limited to sample extraction, homogenization, and digestion in genomic, proteomic, lipidomic, metabolomic and small molecule study areas;
- Pathogen inactivation (useful in vaccine development, infectious disease research, and more);
- Protein purification, and in the control of chemical reactions, particularly enzymatic (useful in drug design and development);
- and immunodiagnostics (useful in the development and detection of biomarkers).
INTELLECTUAL PROPERTY
PBIO has secured their technology through fourteen issued United States patents and ten issued foreign patents covering multiple applications of pressure cycling technology in the life sciences field. They also have additional patents pending. Research indicates that Pressure Bio Science, Inc. is the only company globally to have patents in this new science sector.
NightFood, Inc. (NGTF 0.33 )* Has healthy night-time food specially formulated for nighttime snackers. The Company has an exclusive agreement with RFI, natural ingredient manufacturer and proprietor of Chocamine, a patented cocoa extract which helps with cravings and mood (calmness), and promotes feelings of satiety.
Americans keep gaining more weight. People have the tendency to grab for goodies at the end of the evening as they relax to enjoy some T.V. Eating and snacking too late at night is a contributing factor to gaining weight. Seventy percent of adults, ages 18-54, snack in the hour or two before bed. Chocamine delivers the health benefits of chocolate to the body (amino acids, minerals and polyphenols) without the added sugars, caffeine or fat.
People give in to the intense hunger cravings that leads to the consumption of sugary, salty or calorie dense foods to satisfy their appetite and cravings. Most of the snacks that people typically eat can impair sleep, causing a person to wake up feeling unrested. Night Food offers better-for-you alternatives to high-calorie and sleep disruptive junk foods.
The company product line currently includes snack bars in two flavors, either Cookies and Dreams or Midnight Chocolate Crunch. The company recently reported that it is looking into expanding the number of flavors in the NightFood bar line, and also manufacturing products in different snack formats, like ice cream or “bites”
Consumers spend over $50 billion/year on night-time snacks…over $1B every week. In general, snacking trends have shifted much healthier over the past several years, but industry research continues to show that the least healthy choices of the day occur as we get closer to bedtime. In fact, the four most popular nighttime snack categories, in order, are salty snacks (chips, pretzels, popcorn), ice cream, chocolate candy, and cookies,
Management believes that, just as there are energy versions of many popular foods (energy jerky, energy candy, energy waffles, energy gum, energy chips, energy bars), foods can also be formulated to be more nighttime appropriate and sleep-friendly.
We’ve seen it happen with low-carb, we’ve seen it happen with gluten-free. Can it happen with nighttime snacking as well?
Leo Motors (LEOM: $ 0. 11 )* has patents for the electric battery industry which we will be writing about in upcoming weekly reports. They have developed a lithium battery that can operate vehicles in sub-zero climates. Their subsidiary LGM has developed battery technology supported by the Korean government to make it possible to use electric battery technology for fishing boats. They have a cartridge system which is a light-weight replacement method of swapping electric batteries.
Fishing has been harmed by the noise and oil leaks from internal combustion engines. LGM has solved that problem and besides eliminating the toxic problem, operating costs are reduced by 25%.
In addition they have a special patent for averting electric hazards and shocks. Leo developed the Internet of Things for e-boats which is networked and connected with an Android Operating System. Leo’s power supply system is CAN (Controller Area Network) based, which enables mobile diagnostics between mobile devices and boats using the Leo technology.
Leo is developing a battery swap system for Kalmado in Puerto Princesa, Philippines, a world famous tourist attraction, which is focused on green energy. They will be converting 100 boats as the environment is expected to become 100% free of the toxicity from internal combustion engines. Also, Leo has developed a battery swap system for Go-Karts to be used in malls in China, Korea and Myanmar. Leo Motors has a new carbon nanotube battery power pack that functions and supplies full power in extreme low temperatures such as below 49 degrees without the need for grid electricity.
Skinvisible ( SKVI: $ 0.03 )*: they have developed skin care products using its patented Invisicare polymer delivery systems and transdermal cannabis products from hemp-derived CBD, with its new developments to include cannabinoids from marijuana CBD and THC.
Where To Invest Now
Fundamental Analysis Stocks To Buy with Stops
Using fundamentals the following are stocks to trade hypothetically. They have done well. We have taken numerous profits as indicated on the table below. In addition many have been stopped out with small losses. All indicated on the table below, balance is critical.
Alibaba has made a few points. We are raising the stop loss price. We have no position in Alcoa AA.
Flushing Financial FFIC fell below the 50 day price moving average on March 3rd, which was a selling opportunity. We would take profits in the Flushing Financial.
Boeing is on its way to $ 200.
We are disappointed with Bristol Myers. We originally bought BMY at $ 49.20 back on October 17th, sold on stop at 55.45 December 7th.
Hecla Mining had been previously stopped out profitably at $ 5.64 on Dec 15th. Try to re-buy on dips to $ 5.65.
We took profits on ENZ but still want to buy at lower prices.
The HDGE is finally relevant at this time. It is a decent long.
| Symbol | Name | Business Description | PE | P/S | MV mln | Price | Buy or Sell Limit | Stop Loss
Or offset |
| BABA | Alibaba | China; more of a retailer than Amazon | 50.67 | 13.21 | 275.5B | 123.22 | Bought @ $ 111 on 4/7/17 opening | 112x |
| AMZN | Amazon | Catalog & Mail Order | 189 | 2.90 | 394B | 959.84 Long | Sell on stop | 910x |
| SIMO | Silicon Motion | Semiconductor solutions for mobile storage and communications | 9.7 | 2.5 | 1.39B | 49.35 | 39.10
01/28/17 |
49.40x |
| CIO | City Office
REIT |
Real Estate Investment Trust high quality Offices | 292 | 5.8 | 396Mln | 12.10 | Re Buy at 12.12 | 11.50x |
| TPC | Tutor Perini | Construction | 12 | 0.25 | 1.3B | 26.40
Stopped out28.90 05/04 |
19.40
10/31/16 |
28.90x new stop loss |
| SAVE | Spirit Airlines | Discount Airline | 13 | 1.6 | 3.6B | 53.82 | 48.10 | 51.00 stopped out 3/17/17 |
| BMY | Bristol Myers | Biopharmaceutical Products | 28 | 5.1 | 94.9B | 54.02
|
Sold at 52.80x
|
Bought 56.20
03/08/17 |
| BA | Boeing | Aerospace, commercial jetliners, military systems | 14 | 0.85 | 81B | 180.76 | Long at
132 10/04/16 |
New stop loss at $ 174 |
| HL | Hecla Mining | Basic Materials | 44 | 3.61 | 1.7B | 5.88
Look for re-entry |
Long at 5.24 3/3/17
Sold at $4.84 |
4.85x Needs to stay above $ 5 to be long |
| FFIC | Flushing Financial | Bank Holding company Savings and loans | 13 | 3,5 | 592Mln | 27.50 | 19.10
06/27 |
Selling opportunity |
| AA | Alcoa | Aluminum Processing and Technology | N/A | 0.4 | 9.5B | 32.29
No position |
21.15 originally bought 2/8/16 | Sold at 37.89 Re-Bought at 34.40 3/10/17 |
| ENZ | Enzo Biochem | Life Sciences | NA | 1.35 | 134M | 9.02 | Bought
at 5.13 10/7/16 |
Sold on Opening Monday 4/3/17
Sold 8.43 |
| BAC | Bank of America | Commercial Bank | 10 | 2.02 | 165.3B | 23.05
|
Bought at 15.42
9/30/16 |
23.60x stopped out on 3/21/17 |
| HDGE | Advisor Shares | Ranger Bear ETF | 9.02
|
New Long at 8.95 5/15 | Must close above 8.95 to be long : |
Rule 17B Attestations and Disclaimers
Princeton Research, Inc. has approximately 2,581,578 shares of AIVN both free and restricted and represents them for Investor relations. Princeton also has about 40,000 shares of TXGE. Princeton is paid $ 1,500 per month from RMS Medical Products. Princeton has bought 81,100 shares of RMS Medical Products. Princeton was paid $ 2,500 to write a report on Xinergy. Princeton has signed a contract with CBLI to be paid $ 2500 for July and August for investor relations. Princeton has been engaged by Target Energy. No contract is currently in place. Princeton was paid about 500,000 restricted shares of Leo Motors.
When there is no movement in penny stocks, even though there is none or very small losses, we will liquidate ( sold AIVN on stop ) even though we like the company, if money is needed for better opportunities.
We now believe REPR represents upside opportunity. The Target ADR trades at about $ 4.50 in U.S. vs 0.05 in Australia. Princeton owns 400,000 Australia shares and about 900 U.S. ADR’s.
Pursuant to the provisions of Rule 206 (4) of the Investment Advisers Act of 1940, readers should recognize that not all recommendations made in the future will be profitable or will equal the performance of any recommendations referred to in this e-mail issue. Princeton may buy or sell its free-trading shares in companies it represents at any time.
CONTACT
Please Direct All Inquiries To:
Mike King
(702) 650-3000